• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Ultrasound Med . Lung Ultrasound in COVID-19 and Post-COVID-19 Patients, an Evidence-Based Approach

tetano

Editor, Senior Moderator
J Ultrasound Med


. 2021 Dec 3.
doi: 10.1002/jum.15902. Online ahead of print.
Lung Ultrasound in COVID-19 and Post-COVID-19 Patients, an Evidence-Based Approach


Libertario Demi[SUP] 1 [/SUP], Federico Mento[SUP] 1 [/SUP], Antonio Di Sabatino[SUP] 2 [/SUP], Anna Fiengo[SUP] 2 [/SUP], Umberto Sabatini[SUP] 2 [/SUP], Veronica Narvena Macioce[SUP] 3 [/SUP], Marco Robol[SUP] 1 [/SUP], Francesco Tursi[SUP] 3 [/SUP], Carmelo Sofia[SUP] 4 [/SUP], Chiara Di Cienzo[SUP] 4 [/SUP], Andrea Smargiassi[SUP] 4 [/SUP], Riccardo Inchingolo[SUP] 4 [/SUP], Tiziano Perrone[SUP] 2 5 [/SUP]



Affiliations

Abstract

Objectives: Worldwide, lung ultrasound (LUS) was utilized to assess coronavirus disease 2019 (COVID-19) patients. Often, imaging protocols were however defined arbitrarily and not following an evidence-based approach. Moreover, extensive studies on LUS in post-COVID-19 patients are currently lacking. This study analyses the impact of different LUS imaging protocols on the evaluation of COVID-19 and post-COVID-19 LUS data.
Methods: LUS data from 220 patients were collected, 100 COVID-19 positive and 120 post-COVID-19. A validated and standardized imaging protocol based on 14 scanning areas and a 4-level scoring system was implemented. We utilized this dataset to compare the capability of 5 imaging protocols, respectively based on 4, 8, 10, 12, and 14 scanning areas, to intercept the most important LUS findings. This to evaluate the optimal trade-off between a time-efficient imaging protocol and an accurate LUS examination. We also performed a longitudinal study, aimed at investigating how to eventually simplify the protocol during follow-up. Additionally, we present results on the agreement between AI models and LUS experts with respect to LUS data evaluation.
Results: A 12-areas protocol emerges as the optimal trade-off, for both COVID-19 and post-COVID-19 patients. For what concerns follow-up studies, it appears not to be possible to reduce the number of scanning areas. Finally, COVID-19 and post-COVID-19 LUS data seem to show differences capable to confuse AI models that were not trained on post-COVID-19 data, supporting the hypothesis of the existence of LUS patterns specific to post-COVID-19 patients.
Conclusions: A 12-areas acquisition protocol is recommended for both COVID-19 and post-COVID-19 patients, also during follow-up.

Keywords: COVID-19; SARS-CoV-2; artificial intelligence; lung ultrasound; post-COVID-19.
 
Back
Top Bottom